Dr Emma Thornton
Postdoctoral Research Fellow, University of Adelaide
Parkinson’s disease (PD) affects 1 in 350 Australians with 30 new cases every day. In PD, dopamine levels decrease due to a slow and progressive death of brain cells. It is critical for the treatment of PD to target this cell death. Dr Emma Thornton is the only researcher in the world who has identified that substance P plays a role in dopamine cell death. When we block its action with an antagonist, we protect dopamine cells and restore brain function. Testing this discovery in patients is in progress.
For a full list of Dr Thornton's publications, please visit her Google Scholar page.
Leonard AV, Thornton E, Vink R (2015). The relative contribution of edema and hemorrhage to raised intrathecal pressure after traumatic spinal cord injury. Journal of Neurotrauma 32 (6), 397-402.
Plummer S, Van Den Heuvel C, Thornton E, Corrifan F, Cappai R (2016). The neuroprotective properties of the amyloid precursor protein following traumatic brain injury. Aging and disease 7 (2), 163.
Thornton E, Vink R (2015). Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease, Neural regeneration research 10 (9), 1403